Russian scientists have created a cure for anxiety after COVID-19: Society: Russia: Lenta.ru
A high-tech project of the National Technological Initiative (NTI) Avineiro has developed and is testing a new drug for anxiety, Aviander, which should help those who have recovered from COVID-19. Told about it RIA News in the press service.
It is noted that anxiety disorders are among the most common consequences of coronavirus. Generalized anxiety disorder (GAD) is characterized by persistent, excessive, and unrealistic anxiety about everyday things.
The medical director of the Avineiro project, Elena Yakubova, said that as a result of eight weeks of therapy with Aviander, the overall score on the Hamilton Anxiety Scale (HARS) has been more than halved. She added that the drug “with high selectivity affects a number of adrenergic receptors and a group of serotonin receptors.” According to her, “Aviander” provides anxiolytic, antidepressant and pro-cognitive effects.
Yakubova also explained.
As the leader of the Neuronet working group, Andrey Ivashchenko has significant potential in the neurorehabilitation of postcoid disorders of the central nervous system. At the same time, if the hypothesis is confirmed in the third phase of the clinical trial, the Ministry of Health may decide on accelerated registration.
At the end of November, the head of the Federal Medical and Biological Agency (FMBA) Veronika Skvortsova said that the drug for coronavirus infection “MIR-19” will be effective against the omicron strain. The drug is developed on the basis of microRNA, it is safe for humans and does not affect its genome and immunity, says Skvortsova. She points out that the drug turns off the copying of the virus and prevents severe forms of the disease.